SLC2A4 and type 2 diabetes mellitus: In view of the crucial roles of GLUT4 in glucose metabolism, which make it a possible drug screening target for IR and T2DM therapy, we established a firefly luciferase reporter screening system, driven by the GLUT4 gene promoter, to screen for potential compounds enhancing GLUT4 expression.